
Key Platform Technologies
Inventprise has developed various IP technologies to add value at different stages of the vaccine manufacturing process. Our advanced purification and conjugation technology produces high potency polysaccharide vaccines. Our heat-stable technology reduces cold storage and distribution costs of viral vaccines. All of our platform technologies are under patent protection and we are open to licensing them to third parties.

Conjugation Technology
We have created a platform polysaccharide conjugation technology which gives high potency and yield.
Heat Stable Viral Vaccine
Our proprietary process allows the production of low volume (0.5mL or less), thermostable, oral viral vaccines.